Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. Januar 2023 13:32 ET | Quelle: AXIM Biotechnologies, Inc.

AXIM Biotechnologies Files Patent on Fentanyl Neutralizing Antibody Test, Applies for DEA License to Work With Controlled Substance

Diagnostic Healthcare Solutions Company Developing New Test Designed to Measure Neutralizing Antibodies of Deadly Opioid Fentanyl SAN DIEGO, CA, Jan. 17, 2023 (GLOBE NEWSWIRE) -- via...
17. Januar 2023 09:00 ET | Quelle: Avalon GloboCare Corp.

Avalon GloboCare Announces Issuance of Key U.S. Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules

FREEHOLD, N.J., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a leading global developer of innovative cell-based technologies and...
17. Januar 2023 08:30 ET | Quelle: BYND Cannasoft Enterprises, Inc.

Israeli Cannabis Technology Company BYND Cannasoft Enterprises Files US Provisional Patent Application and Full Scale PCT Application for Its EZ-G Device

ASHKELON, Israel and VANCOUVER, British Columbia, Jan. 17, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today...
17. Januar 2023 07:10 ET | Quelle: Immuron Limited

Immuron Receives European Patent on Drug Composition to Treat Clostridioides difficile Associated Disease

MELBOURNE, Australia, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company that has developed two...
13. Januar 2023 15:00 ET | Quelle: Nurexone Biologic Inc

United States Patent Office Allows Patent to Exosome Biomedical Company Nurexone

HAIFA, Israel and CALGARY, Alberta, Jan. 13, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (NRX:CVE) (J90:FRA) (the “Company” or “NurExone”), a biopharmaceutical company developing...
12. Januar 2023 09:00 ET | Quelle: Agriforce Growing Systems Ltd.

AgriFORCE Granted Patent from the United States Patent and Trademark Office Related to its Proprietary Methods for Processing Nutritious Foods Under the UN(THINK)™ Foods Brand

VANCOUVER, Jan. 12, 2023 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (“the Company") (NASDAQ: AGRI; AGRIW), an intellectual property (IP)-focused AgTech company dedicated to advancing...
12. Januar 2023 07:30 ET | Quelle: GBT Technologies Inc.

GBT’s Wireless, Motion Detection and Imaging, Continuation Patent Application Received a Notice of Publication

The continuation patent aims to broaden the IP’s scope and extend its coverage within the computer vision field SANTA MONICA, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC...
11. Januar 2023 13:49 ET | Quelle: Innovative Designs Inc.

Innovative Designs Receives Notice of Allowance on Patent Application

Pittsburgh, PA, Jan. 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Innovative Designs (IVDN) is pleased to announce that the United States Patent and Trademark Office (USPTO) has agreed that our...
11. Januar 2023 08:00 ET | Quelle: Recce Pharmaceuticals

Recce Pharmaceuticals to be Granted Anti-Viral Patent in Australia for RECCE® Anti-Infectives

SYDNEY, Australia, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q), the Company developing a new class of synthetic anti-infectives, is pleased to announce the...
10. Januar 2023 09:00 ET | Quelle: BriaCell Therapeutics Corp.

BriaCell Announces New Patent Issuance, Bria-OTS™ IND Timing Guidance, and Additional Clinical Sites to Boost Enrolment

BriaCell’s new patent protects its novel personalized off-the-shelf cell-based technology for breast cancer and multiple other cancer indications until 2040.BriaCell expects to initiate its Bria-OTS™...

Vorherige Seite

Nächste Seite